前言
摘要
1 Heald RJ. The 'Holy Plane’ of rectal surgery. J R Soc Med 1988; 81: 503–8.
2 Enker WE, Laffer UT, Block GE. Enhanced survival of patients with colon and rectal cancer is based upon wide anatomic resection. Ann Surg 1979; 190: 350–60.
3 Enker WE, Kafka NJ, Martz J. Planes of sharp pelvic dissection for primary, locally advanced, or recurrent rectal cancer. Semin Surg Oncol 2000; 18: 199–206.
4 Stelzner F. (2006) Embryologie, vergleichende Anatomie und Genetik der Anokutanregion.In: Chirurgische Proktolo-gie (eds Lange J, Mo¨lle B, Girona J). , pp. 13–30. Springer, Heidelberg.
5 Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003; 21: 2912–9.
6 Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 2006; 244: 602–10.
7 Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 2006; 24: 3570–5.
8 Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007; 99: 433–41.
9 Liang JT, Huang KC, Lai HS, Lee PH, Sun CT. Oncologic results of laparoscopic D3 lymphadenectomy for male sigmoid and upper rectal cancer with clinically positive lymph nodes. Ann Surg Oncol 2007; 14: 1980–90.
10 Schumacher P, Dineen S, Barnett C Jr, Fleming J, Anthony T. The metastatic lymph node ratio predicts survival in colon cancer. Am J Surg 2007; 194: 827–32.
11 Hohenberger W, Reingruber B, Merkel S. Surgery for colon cancer. Scand J Surg 2003; 92: 45–52.
12 Hohenberger W, Merkel S, Weber K. Lymphadenektomie bei Tumoren des unteren Gastrointestinaltrakts. Chirurg 2007; 78: 217–25.
13 Goligher JC. (19845th edition). Incidence and pathology of carcinoma of the colon and rectum. In: Surgery of the Anus, Rectum and Colon (ed. Goligher JC). , p. 445. Baillie`re Tindall, London.
14 Toyota S, Ohta H, Anazawa S. Rationale for extent of lymph node dissection for right colon cancer. Dis Colon Rectum 1995; 38: 705–11.
15 Van Damme J-P, Bonte J. (1990) The more exceptional right colic artery. In: Van Damme J-P, Bonte J (eds.), Vascular Anatomy in Abdominal Surgery, p. 53. Georg Thieme, Stuttgart, New York.
16 Hermanek P, Hermanek P Jr. Role of the surgeon as a variable in the treatment of rectal cancer. Semin Surg Oncol 2000; 19: 329–35.
17 Hermanek P, Mansmann U, Staimmer DS, Riedl S, Hermanek P. The German experience: the surgeon as a prognostic factor in colon and rectal cancer surgery. Surg Oncol Clin N Am 2000; 9: 33–49.
18 Jass JR, Sobin LH. (1989) Histological Typing of Intestinal Tumours (2nd edition). Springer, Berlin, Heidelberg, New York.
19 Sobin LH, Wittekind Ch. (2002) UICC TNM classification of malignant tumors (6th edition). John Wiley & Sons, New York.
20 Soreide O, Norstein J, Fielding LP, Silen W. (1997) International standardization and documentation of the treatment of rectal cancer.In: Rectal cancer surgery. Optimisation – standardisation – documentation (eds Soreide O,Norstein J), pp. 405–45. Springer, Berlin, Heidelberg, New York.
21 Le Blanc M. (2006 2nd edition) Constructing Prognostic Groups by tree-based partitioning and peeling methods. In: Crowley J (ed.) Handbook of Statistics in Clinical Oncology, pp. 365–82. Chapman & Hall, New York.
22 Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74–108.
23 Martling A, Holm T, Rutqvist LE, Johansson H, Moran BJ, Heald RJ, Cedermark B. Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg 2005; 92: 225–9.
24 Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedermark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stock-holm Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000; 356: 93–6.
25 Kapiteijn E, Putter H, Van de Velde CJ; Cooperative investigators of the Dutch Colorectal Cancer Group. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Nether-lands. Br J Surg 2002; 89: 1142–9.
26 Wibe A, Møller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, Langmark F, Myrvold HE, Søreide O; Norwegian Rectal Cancer Group. A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002; 45: 857–66.
27 Cecil TD, Sexton R, Moran BJ, Heald RJ. Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 2004; 47: 1145–50.
28 Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731–40.
29 Bosset JF, Collette L, Calais G et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Eng J Med 2006; 355: 1114–23.
30 Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005; 23: 5644–50.
31 Jagoditsch M, Lisborg PH, Jatzko GR, Wette V, Kropfitsch G, Denk H, Klimpfinger M, Stettner HM. Long-term prognosis for colon cancer related to consistent radical surgery: multivariate analysis of clinical, surgical, and pathologic variables. World J Surg 2000; 24: 1264–70.
32 Bokey EL, Chapuis PH, Dent OF, Mander BJ, Bissett IP, Neurland RC. Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum 2003; 46: 860–6.
33 Schrag D, Cramer LD, Bach PB, Cohen AM, Warren JL, Begg CB. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA 2000; 284: 3028–35.
34 Staib L, Link KH, Blatz A, Beger HG. Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients – monoinstitutional experience. World J Surg 2002; 26: 59–66.
35 Hilska M, Roberts PJ, Ko¨ssi J, Paajanen H, Collan Y, Laato M. The influence of training level and surgical experience on survival in colorectal cancer. Langenbecks Arch Surg 2004; 389: 524–31.
36 Jessup JM, Steward A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race ⁄ ethnicity, age and differentiation JAMA2005; 294: 2703–11.
37 Sjo OH, Lunde OC, Nygaard K, Sandvik L, Nesbakken A. Tumour location is a prognostic factor for survival in colonic cancer patients. Colorectal Dis 2008; 10: 33–40.
38 Wind J, Ten Kate FJ, Kiewiet JJ, Lagarde SM, Slors JF, Van Lanschot JJ, Bemelman WA. The prognostic significance of extracapsular lymph node involvement in node positive patients with colonic cancer. Eur J Surg Oncol 2008; 34: 390–6.
39 Gall FP, Hermanek P. Wandel und derzeitiger Stand der Behandlung des colorectalen Carcinoms. Chirurg 1992; 63: 227–34.
40 Birgisson H, Talba¨ck M, Gunnarsson U, Pa˚hlman L, Glimelius B. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005; 31: 845–53.
41 Iversen LH, Nørgaard M, Jepsen P et al. Trends in colorectal cancer survival in northern Denmark: 1985–2004. Colorectal Dis 2007; 9: 210–7.
42 Mammen JM, James LE, Molloy M, Williams A, Wray CJ, Sussman JJ. The relationship of lymph node dissection and colon cancer survival in the Veterans Affairs Central Cancer Registry. Am J Surg 2007; 194: 349–54.
43 Hermanek P Jr, Wiebelt H, Riedl S, Staimmer D, Hermanek P. Langzeitergebnisse der chirurgischen Therapie des Coloncarcinoms. Chirurg 1994; 65: 287–97.
44 Kessler H, Mansmann U, Hermanek P Jr, Riedl S, Staimmer D, Hermanek P: for the Study Group Colo-Rectal Carcinoma (SGCRC) Does the surgeon affect outcome in colon carcinoma? Semin Colon Rectal Surg 1998; 9: 33–40
45 Taal BG, Van Tinteren H, Zoetmulder FA; NACCP group Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III Br J Cancer 2001; 85: 1437–43
46 Andre´ T, Boni C, Mounedji-Boudiaf L et al Multicenter International Study of Oxaliplatin ⁄ 5-Fluorouracil ⁄ Leucovo-rin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Eng J Med 2004; 350: 2343–51
47 O’Connell JB, Maggard MA, Ko CY Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 2004; 96: 1420–5
48 Link KH, Kornmann M, Staib L, Redenbacher M, Kron M, Beger HG; Study Group Oncology of Gastrointestinal Tumors Increase of survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: results of a randomized trial comparing modulation of 5-FU + levami-sole with folinic acid or with interferon-alpha Ann Surg 2005; 242: 178–87
49 Frazer JE, Robbins RH On the factors concerned in causing rotation of the intestine in man J Anat Physiol 1915; 50: 75–110
50 Patten BM (1968 3rd edition) Human Embryology P 417 McGraw-Hill, New York
51 Hermanek P. Multivisceral resection of colorectal cancer -experiences of the Colorectal Cancer Study Group Langen-becks Arch Chir Suppl 1992 Kongressbd 1992; 95–100
52 Hunter JA, Ryan JA Jr, Schultz P En bloc resection of colon cancer adherent to other organs Am J Surg 1987; 154: 67–71
53 Read TE, Mutch MG, Chang BW, McNevin MS, Fleshman JW, Birnbaum EH, Fry RD, Caushaj PF, Kodner IJ Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon J Am Coll Surg 2002; 195: 33–40
54 Averbach AM, Jacquet P, Sugarbaker PH Surgical technique and colorectal cancer: impaction on local recurrence and survival Tumori 1995; 81: 65–71
55 Meyer T, Merkel S, Reingruber B, Papadopoulos T, Wein A, Hahn E, Hohenberger W. The benefit of adjuvant chemo-therapy in colon carcinoma UICC stage III depends on surgical quality. Results of the intact I trial Onkologie 2008; 31(Suppl. 1): 80–1.
联系客服